Literature DB >> 6686526

Electrocardiographic, echocardiographic and ventriculographic characterization of hypertrophic non-obstructive cardiomyopathy.

H Yamaguchi, S Nishiyama, S Nakanishi, S Nishimura.   

Abstract

HNCM tends to have more diffuse or generalized hypertrophy than HOCM, although these two types are not fundamentally different in aetiology (genetic). Extreme ASH is primarily related to a hereditary factor while HNCM, including apical hypertrophy, seems to be based on an abnormal disposition to produce myocardial hypertrophy in response to endogenous or exogenous stimulation such as catecholamines, chronic anoxia, hypertension or even aging. Hypertension by itself, however, can not be a cause of apical hypertrophy. The configuration of left ventricular hypertrophy in HCM can be divided roughly into several patterns: ASH, apical, postero-inferior, generalized or diffuse types, etc. ASH is not an essential morphology for HNCM. Apical hypertrophy is the only specific hypertrophic pattern which shows characteristic ECG abnormalities (giant negative T waves and high QRS voltage in left precordial leads). Inverted T waves combined with high QRS voltage tends to be a reflection of a localized hypertrophic portion in the left ventricular free wall. Abnormal Q waves associated with left axis deviation usually suggest marked septal hypertrophy. They seem to be related to conduction disturbances in myopathic septum.

Entities:  

Mesh:

Year:  1983        PMID: 6686526     DOI: 10.1093/eurheartj/4.suppl_f.105

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  A transplanted heart with an unusual diagnostic dilemma.

Authors:  Milind Y Desai; John Jarcho; Howard Cooper; Finn Mannting
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

2.  Apical hypertrophic cardiomyopathy: diagnosed by cardiac magnetic resonance imaging.

Authors:  Mehmet Ates; Raymond Y Kwong; Martin J Lipton; Servet Tatli
Journal:  Tex Heart Inst J       Date:  2006

Review 3.  Electrovectorcardiographic diagnosis of left septal fascicular block: anatomic and clinical considerations.

Authors:  Andrés Ricardo Pérez Riera; Celso Ferreira; Celso Ferreira Filho; Adriano Meneghini; Augusto Hiroshi Uchida; Paulo Jorge Moffa; Edgardo Schapachnik; Sergio Dubner; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-04       Impact factor: 1.468

4.  Apical hypertrophic cardiomyopathy presenting as recurrent unexplained syncope.

Authors:  Yusuf Kasirye; Janaki Ram Manne; Narendranath Epperla; Sowjanya Bapani; Romel Garcia-Montilla
Journal:  Clin Med Res       Date:  2011-08-04

Review 5.  Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.

Authors:  Daniel L Jacoby; Eugene C DePasquale; William J McKenna
Journal:  CMAJ       Date:  2012-10-29       Impact factor: 8.262

6.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.

Authors:  J C C Moon; N G Fisher; W J McKenna; D J Pennell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

7.  Electromechanical relationship in hypertrophic cardiomyopathy.

Authors:  Xiaoping Lin; Hsin-Yueh Liang; Aurelio Pinheiro; Veronica Dimaano; Lars Sorensen; Miguel Aon; Larisa G Tereshchenko; Yihan Chen; Meixiang Xiang; Theodore P Abraham; M Roselle Abraham
Journal:  J Cardiovasc Transl Res       Date:  2013-06-15       Impact factor: 4.132

Review 8.  Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy.

Authors:  Radu Ovidiu Rosu; Ana Lupsor; Alexandru Necula; Gabriel Cismaru; Simona Sorana Cainap; Daniela Iacob; Cecilia Lazea; Andrei Cismaru; Alina Gabriela Negru; Dana Pop; Gabriel Gusetu
Journal:  Diagnostics (Basel)       Date:  2022-02-14

9.  Yamaguchi syndrome: A mimicer of acute coronary syndrome.

Authors:  Manish Ruhela; Rakesh Kumar Ola; Neeraj Chaturvedi; Rajeev Bagarhatta
Journal:  J Family Med Prim Care       Date:  2022-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.